clinical trial Archive — Page 1 of 15

(iStock)
July 3, 2026

Vanderbilt Center for Cognitive Medicine seeks participants for trial evaluating Alzheimer’s disease-related psychosis treatment

The ADEPT-4 study evaluates KarXT, an oral medication that may reduce hallucinations and delusions.

July 2, 2026

Trial of novel device aiding patients with acute decompensated heart failure

The device has the potential to reduce the length of stay for ADHF patients by measuring their response to diuretic medication in real time using algorithms, allowing the process of removing fluid to be more efficient.

June 9, 2026

Study: Lung biopsy cryoprobe increases diagnostic yield over standard forceps

The FROSTBITE-2 trial used the 1.1-millimeter cryoprobe which, unlike the larger probes, is small enough to remove the biopsy specimen through the working channel without having to remove the scope, which increases safety.

June 5, 2026

New research: Heart drug may also limit the spread of cancer

For the past 20 years, Vanderbilt Health researchers have been studying ifetroban for its potential to treat conditions ranging from fibrotic lung disease to heart failure in patients with Duchenne muscular dystrophy.

(iStock)
May 18, 2026

Study finds benefit in genotype-guided care for depression

Genetic variants known to slow or speed metabolism of drugs for depression and anxiety disorders are very common.

April 23, 2026

Vanderbilt Health implants novel device to treat aortic regurgitation in high-risk patients

With the addition of the J-Valve device, Vanderbilt Health now offers minimally invasive procedures to implant devices treating every valve disease. The trial is still enrolling new patients, so other high-risk patients with aortic regurgitation could qualify.